NDC 0603-3214

NDC 0603-3214

NDC 0603-3214 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 0603-3214
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 0603-3214-02 [00603321402]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA077749
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-03-31
Marketing End Date2017-10-31

NDC 0603-3214-32 [00603321432]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA077749
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-03-31
Marketing End Date2017-10-31

NDC 0603-3214-34 [00603321434]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA077749
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2006-03-31
Marketing End Date2017-10-31

NDC 0603-3214-10 [00603321410]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA077749
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2006-03-31
Marketing End Date2017-10-31

NDC 0603-3214-22 [00603321422]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA077749
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-03-31
Marketing End Date2017-10-31

NDC 0603-3214-20 [00603321420]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA077749
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-03-31
Marketing End Date2017-10-31

NDC 0603-3214-16 [00603321416]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA077749
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-03-31
Marketing End Date2017-10-31

NDC 0603-3214-21 [00603321421]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA077749
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-03-31
Marketing End Date2017-10-31

NDC 0603-3214-28 [00603321428]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA077749
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-03-31
Marketing End Date2017-10-31

Drug Details

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.